APYX MEDICAL CORP (APYX) Stock Price, Forecast & Analysis
USA - NASDAQ:APYX - US03837C1062 - Common Stock
APYX Key Statistics, Chart & Performance
The current stock price of APYX is 4.33 USD. In the past month the price increased by 39.23%. In the past year, price increased by 243.65%.
APYX Latest News, Press Relases and Analysis
APYX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.82 | 224.21B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.49 | 205.21B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.3 | 154.29B | ||
| SYK | STRYKER CORP | 27.89 | 140.44B | ||
| IDXX | IDEXX LABORATORIES INC | 56.59 | 57.08B | ||
| BDX | BECTON DICKINSON AND CO | 13.32 | 55.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.3 | 50.24B | ||
| RMD | RESMED INC | 25.54 | 36.90B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.34 | 34.23B | ||
| PODD | INSULET CORP | 73.71 | 23.71B | ||
| DXCM | DEXCOM INC | 32.05 | 23.38B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.13 | 17.83B |
Related stock screener links
About APYX
Company Profile
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. The firm's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. The company specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Company Info
APYX MEDICAL CORP
5115 Ulmerton Rd
Clearwater FLORIDA 33760 US
CEO: Charles D. Goodwin II
Employees: 220
Phone: 18005372790
APYX MEDICAL CORP / APYX FAQ
Can you describe the business of APYX MEDICAL CORP?
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. The firm's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. The company specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Can you provide the latest stock price for APYX MEDICAL CORP?
The current stock price of APYX is 4.33 USD. The price increased by 8.25% in the last trading session.
Does APYX stock pay dividends?
APYX does not pay a dividend.
How is the ChartMill rating for APYX MEDICAL CORP?
APYX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for APYX stock?
APYX MEDICAL CORP (APYX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.36).
What is APYX MEDICAL CORP worth?
APYX MEDICAL CORP (APYX) has a market capitalization of 163.76M USD. This makes APYX a Micro Cap stock.
Can you provide the upcoming earnings date for APYX MEDICAL CORP?
APYX MEDICAL CORP (APYX) will report earnings on 2026-03-11, after the market close.
APYX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to APYX. When comparing the yearly performance of all stocks, APYX is one of the better performing stocks in the market, outperforming 98.31% of all stocks.
APYX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APYX. Both the profitability and financial health of APYX have multiple concerns.
APYX Financial Highlights
Over the last trailing twelve months APYX reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 56.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.66% | ||
| ROE | -237.96% | ||
| Debt/Equity | 4.74 |
APYX Forecast & Estimates
10 analysts have analysed APYX and the average price target is 4.08 USD. This implies a price decrease of -5.77% is expected in the next year compared to the current price of 4.33.
For the next year, analysts expect an EPS growth of 44.05% and a revenue growth 5.75% for APYX